Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Shilpa Medicare.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Alebund, Carsgen, GC Biopharma, Hengrui, Hope Medicines, Takeda.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Innocare, Innovent, Lumosa.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Advancell Isotopes, Astellas, Entera Bio, Harbour Biomed, Iaso Biotherapeutics, Metis Techbio, Rapt Therapeutics, Sagimet Biosciences.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Adocia, Clover, Hutchmed, Iregene, Mabwell, Vor Bio.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Alterity, Carsgen, HEnlius, Hope, Ono, Ribomic.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Kazia, Mindrank, Radiopharm.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ascletis, Kura, Teva.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Asceltis, Carsgen, Corestemchemon, Hightide Therapeutics, MagicRNA, Prota, QL Biopharmaceutical, Sagimet.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Atom, Eisai, Huadaong, Ideaya, Ipsen, Iregene, JCR Pharmaceuticals, Junshi, Merck, Takeda.